Analytics

Feliza Mirasol is the science editor for 

Articles

Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, talks about the differences in designing E&L testing for combination products vs. conventional pharmaceuticals.

Distinguishing E&L Testing for Combination Products (AAPS PharmSci 360)

Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, discusses the differences in how E&L study design should be approached based on whether the study  is following ISO or USP standards. 

Discussing E&L Study Design Between ISO and USP (AAPS PharmSci 360) 

Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, highlights one approach to ensuring the continuation of analytical expertise.

Ensuring the Next Generation of Analytical Experts (AAPS PharmSci 360)

Jorie Kassel is Laboratory Division Manager at Particle Technology Labs.

Using image analysis to characterize complex finished products is crucial in particle analysis.

Differentiating Particle Size and Shape Information in Drug Products with Multiple Components

Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, discusses ways that labs are addressing the pressure of rapid analytical turnaround times.

Addressing the Analytical Challenge of Meeting Quick Turnaround Times (AAPS PharmSci 360)

Jennifer Markarian is a contributing editor for 

As new analytical technologies advance, insight into the twin-screw granulation process is growing.

Exploring Advances in Twin-Screw Extrusion for Solid-Dosage Drugs

Pamela James, PhD, is vice-president, Product, Vector Laboratories.

Capturing the nuances of immune cell phenotype and function can be achieved using glycosylation analysis. 

Using Glycobiology to Study the Nuances of Immune Cells

With advancements in analytical technologies, such as next-generation sequencing, the industry is transitioning towards next-gen technologies for adventitious agent testing.

A Look at Next-Gen Technologies in Adventitious Agent Testing

Under the partnership, Sartorius will leverage SPARTA Biodiscovery’s technology to accelerate development of nanoparticles used for drug delivery.

Sartorius and SPARTA Biodiscovery Partner on Novel Nanoparticle Analysis Platform 

Under the collaboration, Orionis will receive $47 million upfront to leverage its Allo-Glue platform to discover small-molecule monovalent glues.

Analytical Method Development